+2 2 0
Published 9 years ago by trails with 0 Comments
by trails
9 years ago

Oral Disease Modifying Agents for Multiple Sclerosis Are Now More Preferred by Neurologists

A survey of 97 neurologists conducted in June 2015 revealed specialists within the field of neurology are increasingly avoiding prescribing injectables to patients suffering from multiple sclerosis, as orally-available disease modifying-agents (DMAs) continue to gain in popularity.

Continue Reading http://multiplesclerosisnewstoday.com

Join the Discussion

  • Auto Tier
  • All
  • 1
  • 2
  • 3
Post Comment

Here are some other snaps you may like...

discover your
interests.

Check out our front page for a lot more stuff!

Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis

Multiple Sclerosis Research: poor recovery from relapses predict progression

Multiple Sclerosis Research: trial of oral vs. intravenous steroids

Novartis' Gilenya Found to Have Long-Term Positive Effects on Patients with Relapsing-Remitting Multiple Sclerosis

Identifying MS Gene Mutations Could Make Personalized Treatment Possible